BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38480049)

  • 1. Epithelioid cell histiocytoma associated with IRF2BP2::NTRK1 fusion.
    Wood BA; Carr U; Van Vliet C; Mesbah Ardakani N
    Pathology; 2024 Feb; ():. PubMed ID: 38480049
    [No Abstract]   [Full Text] [Related]  

  • 2. Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature.
    Kazlouskaya V; Ho J; Jedrych J; Karunamurthy A
    J Cutan Pathol; 2021 Jul; 48(7):837-841. PubMed ID: 33217002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.
    Dickson BC; Swanson D; Charames GS; Fletcher CD; Hornick JL
    Mod Pathol; 2018 May; 31(5):753-762. PubMed ID: 29327718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
    Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelioid cell histiocytoma with underlying artery damage.
    Miura Y; Misago N; Narisawa Y
    J Dermatol; 2005 Sep; 32(9):721-6. PubMed ID: 16361715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.
    Nakayama R; Togashi Y; Baba S; Kaku Y; Teramoto Y; Sakurai T; Haga H; Takeuchi K
    Diagn Pathol; 2018 May; 13(1):28. PubMed ID: 29747676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
    Ukkola I; Nummela P; Kero M; Tammio H; Tuominen J; Kairisto V; Kallajoki M; Haglund C; Peltomäki P; Kytölä S; Ristimäki A
    Virchows Arch; 2022 Apr; 480(4):807-817. PubMed ID: 35237889
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pekova B; Sykorova V; Mastnikova K; Vaclavikova E; Moravcova J; Vlcek P; Lastuvka P; Taudy M; Katra R; Bavor P; Kodetova D; Chovanec M; Drozenova J; Astl J; Hrabal P; Vcelak J; Bendlova B
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing.
    Chan WH; Shah A; Bae G; Hambro C; Martin BA; Brown R; Novoa R; Kwong BY
    JAAD Case Rep; 2020 Nov; 6(11):1156-1158. PubMed ID: 33134460
    [No Abstract]   [Full Text] [Related]  

  • 11. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.
    Doyle LA; Mariño-Enriquez A; Fletcher CD; Hornick JL
    Mod Pathol; 2015 Jul; 28(7):904-12. PubMed ID: 25857825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelioid cell histiocytoma. A clinicopathologic and immunohistochemical study of eight cases.
    Mehregan AH; Mehregan DR; Broecker A
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):243-6. PubMed ID: 1313055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelioid Fibrous Histiocytoma: A Concise Review.
    Felty CC; Linos K
    Am J Dermatopathol; 2019 Dec; 41(12):879-883. PubMed ID: 30289773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer.
    Wang B; Gao Y; Huang Y; Ou Q; Fang T; Tang C; Wu X; Shao YW
    Clin Lung Cancer; 2019 May; 20(3):e233-e237. PubMed ID: 30691963
    [No Abstract]   [Full Text] [Related]  

  • 16. The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment.
    Pastor TP; Peixoto BC; Viola JPB
    Front Cell Dev Biol; 2021; 9():655307. PubMed ID: 33996817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid Fibrous Histiocytoma With Dot-Like Perinuclear ALK Expression and PRKAR2A-ALK Fusion.
    Dawson K; Bridge JA; Sumegi J; Royce T; Gardner JM; Shalin SC
    Am J Dermatopathol; 2020 Nov; 42(11):861-864. PubMed ID: 32379091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel IRF2BP2::CDX2 Gene fusion in digital intravascular myoepithelioma of soft tissue: An enigma!
    Patton A; Speeckaert A; Zeltman M; Cui X; Oghumu S; Iwenofu OH
    Genes Chromosomes Cancer; 2023 Mar; 62(3):176-183. PubMed ID: 36448218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant.
    Martinez AP; Zou Y; Billings SD; Folpe AL
    J Cutan Pathol; 2018 Feb; 45(2):99-103. PubMed ID: 29068085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelioid Fibrous Histiocytoma with
    Secco LP; Libbrecht L; Seijnhaeve E; Eggers S; Dekairelle AF; De Roo AK
    Dermatopathology (Basel); 2023 Jan; 10(1):25-29. PubMed ID: 36648781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.